The glycine antagonist (+)-HA-966 injected into the nucleus accumbens stimulates locomotion in mice

This publication has 22 references indexed in Scilit:

• Double-Blind, Placebo-Controlled, Crossover Trial of Glycine Adjuvant Therapy for Treatment-Resistant Schizophrenia
  The British Journal of Psychiatry, 1996
• Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted mice
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
• d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
• Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonists
  Life Sciences, 1993
• Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
• Glutamate and glycine co-activate while polyamines merely modulate the NMDA receptor complex
  Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1991
• Stereoselectivity for the (R)‐Enantiomer of HA‐966 (l‐Hydroxy‐3‐Aminopyrrolidone‐2) at the Glycine Site of the N‐Methyl‐d‐Aspartate Receptor Complex
  Journal of Neurochemistry, 1990
• Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease
  Trends in Neurosciences, 1990
• Glycine is a coagonist at the NMDA receptor/channel complex
  Progress in Neurobiology, 1990
• d-Cycloserine: A ligand for the coupled glycine receptor has partial agonist characteristics
  Neuroscience Letters, 1989